Abstract
CA 19-9 has achieved a defined role in the diagnosis, prognosis, and monitoring of patients with pancreatic cancer. For diagnosis, a reference value above 200 u/mL in a nonjaundiced patient with a confirming CT scan has a very high predictive value. For prognosis, a low preoperative value and a normal value after resection predict a good outcome. Similarly, CA 19-9 levels have been used successfully in monitoring the response to neoadjuvant therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 93-101 |
| Number of pages | 9 |
| Journal | Surgical Oncology Clinics of North America |
| Volume | 7 |
| Issue number | 1 |
| State | Published - Mar 24 1998 |
ASJC Scopus subject areas
- Surgery
- Oncology
Fingerprint Dive into the research topics of 'CA 19-9 in pancreatic cancer'. Together they form a unique fingerprint.
Cite this
Ritts, R. E., & Pitt, H. A. (1998). CA 19-9 in pancreatic cancer. Surgical Oncology Clinics of North America, 7(1), 93-101.